Resultado da Busca
16 de fev. de 2021 · Among people diagnosed with metastatic colorectal cancer, approximately 70% to 75% of patients survive beyond 1 year, 30% to 35% beyond 3 years, and fewer than 20% beyond 5 years from diagnosis. The primary treatment for unresectable metastatic CRC is systemic therapy (cytotoxic chemotherapy, biologic therapy such as antibodies to cellular growth factors, immunotherapy, and their combinations.)
17 de out. de 2022 · PURPOSE To develop recommendations for treatment of patients with metastatic colorectal cancer (mCRC). METHODS ASCO convened an Expert Panel to conduct a systematic review of relevant studies and develop recommendations for clinical practice. RESULTS Five systematic reviews and 10 randomized controlled trials met the systematic review inclusion criteria. RECOMMENDATIONS Doublet chemotherapy ...
4 de mar. de 2022 · Colorectal cancer (CRC) is one of the most frequently occurring malignancy tumors with a high morbidity additionally, CRC patients may develop liver metastasis, which is the major cause of death.
2 de nov. de 2020 · The liver is one of the most common sites for cancer metastasis, which leads to secondary hepatic malignancies. Almost all solid tumors, such as melanoma, breast cancer, gastric cancer, colorectal ...
22 de jul. de 2019 · Many colorectal cancers are likely to have spread from the site where they first formed to other parts of the body long before the original tumor can be detected by current screening tests, new study results suggest. Most cancer researchers have assumed that the spread, or metastasis, of tumors typically occurs later in the disease process.
12 de mar. de 2020 · Metastasis is the hallmark of cancer that is responsible for the greatest number of cancer-related deaths. Yet, it remains poorly understood. The continuous evolution of cancer biology research ...
20 de abr. de 2024 · Colorectal cancer is the third most common diagnosis and cause of cancer-related death in both sexes in the United States.[1] Worldwide, the condition remains the third most common malignancy but is second only to lung cancer in its mortality rate.[2] Incidence rates have been decreasing in Western countries, mostly due to the widespread use of colonoscopy screening. However, the condition's ...
